1-20 of 21
Authors: Yoon-Jae Cho
Save search
Sort by
Journal Article

IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY Open Access

PDF
Jacob Henderson and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii362, https://doi.org/10.1093/neuonc/noaa222.370
Published: 04 December 2020
Journal Article

IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA Free

PDF
Jacob Henderson and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii98, https://doi.org/10.1093/neuonc/noz036.143
Published: 23 April 2019
Journal Article

IMMU-03. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA Free

PDF
Alexandra Garancher and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii93, https://doi.org/10.1093/neuonc/noz036.124
Published: 23 April 2019
Journal Article

MEDU-47. A NOVEL TGF-BETA/MYC-DRIVEN MEDULLOBLASTOMA MODEL TO STUDY IMMUNE-TUMOR INTERACTIONS Free

PDF
Jacob Henderson and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii113, https://doi.org/10.1093/neuonc/noz036.205
Published: 23 April 2019
Journal Article

MBRS-65. CHEMI-GENOMIC ANALYSIS OF PATIENT-DERIVED XENOGRAFTS TO IDENTIFY PERSONALIZED THERAPIES FOR MEDULLOBLASTOMA Free

PDF
Jessica M Rusert and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i142, https://doi.org/10.1093/neuonc/noy059.509
Published: 22 June 2018
Journal Article

PDTM-34. COMBINED BET BROMODOMAIN AND CDK2 INHIBITION IN MYC-DRIVEN MEDULLOBLASTOMA Free

PDF
Sara Bolin and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi197, https://doi.org/10.1093/neuonc/nox168.797
Published: 06 November 2017
Journal Article

PDTM-36. FUNCTIONAL GENOMIC ANALYSIS OF MYC-AMPLIFIED MEDULLOBLASTOMA NOMINATES THE TGFB PATHWAY AS A CLINICALLY VIABLE TARGET Free

PDF
Jacob Henderson and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi197, https://doi.org/10.1093/neuonc/nox168.799
Published: 06 November 2017
Journal Article

TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA Free

PDF
David Bakhshinyan and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv54, https://doi.org/10.1093/neuonc/nox083.225
Published: 31 May 2017
Journal Article

PDTB-23. CHEMI-GENOMIC ANALYSIS OF PATIENT-DERIVED XENOGRAFTS TO IDENTIFY PERSONALIZED THERAPIES FOR MEDULLOBLASTOMA Free

PDF
Jessica Rusert and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi154–vi155, https://doi.org/10.1093/neuonc/now212.642
Published: 07 November 2016
Journal Article

Pediatric high-grade glioma: biologically and clinically in need of new thinking Open Access

PDF
Chris Jones and others
Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 153–161, https://doi.org/10.1093/neuonc/now101
Published: 09 June 2016
Journal Article

MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL Free

PDF
Suzana Assad Kahn and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii100, https://doi.org/10.1093/neuonc/now076.14
Published: 30 May 2016
Journal Article

MB-32MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE Free

PDF
Timothy Phoenix and others
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii104, https://doi.org/10.1093/neuonc/now076.30
Published: 30 May 2016
Journal Article

IMPS-26HARNESSING THE MYELOID CHECKPOINT CD47-SIRPa AXIS AGAINST ADULT AND PEDIATRIC MALIGNANT BRAIN TUMORS: A NOVEL IMMUNOTHERAPEUTIC MODALITY Free

PDF
Sharareh Gholamin and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v118, https://doi.org/10.1093/neuonc/nov217.25
Published: 09 November 2015
Journal Article

MB-01NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE Get access

PDF
Suzana Kahn and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Pages iii19–iii20, https://doi.org/10.1093/neuonc/nov061.77
Published: 21 April 2015
Journal Article

MB-11IMPACT OF MOLECULAR SUB-TYPE AND CRANIOSPINAL IRRADIATION (CSI) DOSE ON RELAPSE OF MEDULLOBLASTOMA Get access

PDF
Ange Wang and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii22, https://doi.org/10.1093/neuonc/nov061.87
Published: 21 April 2015
Journal Article

MB-19MEDULLOBLASTOMA SUBTYPES SPECIFY INTER-TUMORAL VASCULAR BLOOD BRAIN BARRIER HETEROGENEITY Get access

PDF
Timothy Phoenix and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii24, https://doi.org/10.1093/neuonc/nov061.95
Published: 21 April 2015
Journal Article

GE-21DRASTIC GENOMIC DIVERGENCE OF RECURRENT MEDULLOBLASTOMA INVALIDATES TARGETED THERAPIES DISCOVERED AT DIAGNOSIS Get access

PDF
Sorana Morrissy and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Pages v100–v101, https://doi.org/10.1093/neuonc/nou256.20
Published: 01 November 2014
Journal Article

HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA Get access

PDF
Robert J. Wechsler-Reya and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii29, https://doi.org/10.1093/neuonc/nou208.22
Published: 01 July 2014
Journal Article

EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Get access

PDF
Yoon-Jae Cho and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii25, https://doi.org/10.1093/neuonc/nou208.9
Published: 01 July 2014
Journal Article

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma Get access

PDF
Shyamal D. Weeraratne and others
Neuro-Oncology, Volume 13, Issue 2, February 2011, Pages 165–175, https://doi.org/10.1093/neuonc/noq179
Published: 22 December 2010